Over the years, I have worked in two other areas of interest: firstly, in the planning and evaluation of the cancer control activities at regional, national and international level; and secondly, in research. With regard to cancer control planning and management, I served as director and CEO of a Comprehensive Cancer Centre for 10 years, and since 2006, I have been the director of the Catalonian Cancer Control Plan. In this capacity, I led the quality assessment of colorectal cancer care at regional level—work that is now extending to all relevant tumours. I also contributed to the EURECCA project, which published the European consensus paper on rectal cancer diagnosis and treatment. This project has now expanded in order to undertake a full European analysis of the comparative quality of cancer care for the main tumour sites.  Additionally, I am a member of the technical group in charge of developing the recommendations of the International Consortium for Health Outcomes Measurement (ICHM) on colorectal cancer. As the scientific coordinator of the Spanish Cancer Strategy, I have been leading the consultation to evaluate the resources, quality indicators and working procedures needed for a high quality cancer department, both for adult and paediatric patients, published by the Spanish Ministry of Health. These are the background documents for the organization of high quality cancer care within the Spanish NHS and were developed with contributions from scientific societies, patient groups and technical experts. From 2011 to 2013, I was the Work Package leader for Health Care within the European Partnership for Action Against Cancer (EPAAC). One of the deliverables for this group was a position paper on multidisiciplinary cancer care, produced with the involvement of all relevant scientific societies, patient groups and cancer plans.  Within the EPAAC initiative, I took part in the preliminary technical discussions of European Reference Networks. The deliverables carried out under my responsibility included an evaluation of cancer care networks, which included three case studies from Belgium, Spain and Italy and contributions from the Netherlands, England, Denmark and France. Currently, I am also involved in the CANCON Joint Action set up in 2014, aiming to create a guide on cancer control plans for EU countries. Recently, I have also taken on the position as leader of a work package on health policy in the Joint Action of Rare Cancers (JARC). My research focuses on the determinants of cancer services utilization and the impact of smoking on cancer trends.  Regarding the analysis of resource utilization, I participate in a group set up by the European Society of Radiation Oncology (ESTRO) charged with assessing both the demand and the available resources for radiotherapy in Europe through an evidence-based approach. I am also involved in a research project assessing the adherence to oral chemotherapy in cancer patients. Globally, I have co-authored more than 170 papers in peer-reviewed journals. Finally, I am also a member of the editorial board of several journals, including the European Journal of Cancer (Epidemiology section) and the European Journal of Cancer Prevention.